{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:11:35Z","timestamp":1761217895272},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1097\/md.0000000000004815","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T08:42:19Z","timestamp":1473928939000},"page":"e4815","source":"Crossref","is-referenced-by-count":4,"title":["Approaching the facts between genetic mutation and clinical practice of hypertrophic cardiomyopathy"],"prefix":"10.1097","volume":"95","author":[{"given":"Xiaoqin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-36-20210302","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290146","article-title":"Hypertrophic cardiomyopathy: from gene defect to clinical disease","volume":"13","author":"Chung","year":"2003","journal-title":"Cell Res"},{"key":"R2-36-20210302","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/CIRCRESAHA.110.223842","article-title":"Understanding cardiomyopathy phenotypes based on the functional impact of mutations in the myosin motor","volume":"111","author":"Moore","year":"2012","journal-title":"Circ Res"},{"key":"R3-36-20210302","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cjca.2014.12.036","article-title":"Right ventricular hypertrophy is associated with cardiovascular events in hypertrophic cardiomyopathy: evidence from study with magnetic resonance imaging","volume":"31","author":"Nagata","year":"2015","journal-title":"Can J Cardiol"},{"key":"R4-36-20210302","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.yjmcc.2011.03.001","article-title":"Cyclosporine attenuates cardiomyocyte hypertrophy induced by raf1 mutants in Noonan and Leopard syndromes","volume":"51","author":"Dhandapany","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"R5-36-20210302","first-page":"e783","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"R6-36-20210302","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"key":"R7-36-20210302","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1074\/jbc.M114.596676","article-title":"Mechanistic heterogeneity in contractile properties of alpha-tropomyosin (tpm1) mutants associated with inherited cardiomyopathies","volume":"290","author":"Gupte","year":"2015","journal-title":"J Biol Chem"},{"key":"R8-36-20210302","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1038\/ncomms6515","article-title":"Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice","volume":"5","author":"Mearini","year":"2014","journal-title":"Nat Commun"},{"key":"R9-36-20210302","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ng.2963","article-title":"Raf1 mutations in childhood-onset dilated cardiomyopathy","volume":"46","author":"Dhandapany","year":"2014","journal-title":"Nat Genet"},{"key":"R10-36-20210302","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nm1101-1236","article-title":"Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of galphaq\/galpha11 in cardiomyocytes","volume":"7","author":"Wettschureck","year":"2001","journal-title":"Nat Med"},{"key":"R11-36-20210302","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/hmg\/dds022","article-title":"Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations","volume":"21","author":"Purevjav","year":"2012","journal-title":"Hum Mol Genet"},{"key":"R12-36-20210302","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1271\/bbb.90586","article-title":"Defective dynamic properties of human cardiac troponin mutations","volume":"74","author":"Lassalle","year":"2010","journal-title":"Biosci Biotechnol Biochem"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004815","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:33:12Z","timestamp":1620959592000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201609130-00036"}},"subtitle":["A case report with RAF1 770C&gt;T mutant"],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":12,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004815","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}